Drug or treatment
Tezepelumab clinical trials
As of November 12, 2026, Find a Trial lists 11 clinical trials of Tezepelumab that are recruiting, at sites in 40 countries (most in United States (5), China (4), Canada (3)). By phase: Phase 3 (5), Phase 2 (1), Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 11Clinical trials
- 40Countries
Newest trials
All recruiting trials (11)
-
Structured physical activity program added to tezepelumab for adults with severe asthma
A 12-week program to help adults with severe asthma who start tezepelumab see if adding guided physical activity improves activity levels and chances of remission.
-
Tezepelumab in real-world CRSwNP: a real-world look at patient outcomes
This study tests tezepelumab in adults with chronic rhinosinusitis with nasal polyps to see how their symptoms and daily life change in routine care over about two years.
-
Tezepelumab for Chinese adults with nasal polyps: a 24-week treatment study
This trial tests whether tezepelumab can improve nasal polyps and symptoms in Chinese adults with chronic rhinosinusitis with nasal polyps who are starting therapy.
-
Real-world use of tezepelumab for chronic rhinosinusitis with nasal polyps in Russia
This study will see how tezepelumab works in adults in Russia who have chronic rhinosinusitis with nasal polyps, with or without asthma.
-
Tezepelumab to reduce maintenance medication in people with severe asthma
This will test whether people aged 12–80 with severe asthma in China who start tezepelumab can safely reduce their regular maintenance medicines while keeping asthma controlled.
-
Tezepelumab with Peanut OIT for Peanut Allergy
This study tests whether adding tezepelumab to peanut oral immunotherapy can help people with peanut allergy build lasting tolerance.
-
Heart-event monitoring for people with severe asthma taking Tezepelumab (Tezspire)
This project will test whether taking tezepelumab (Tezspire) changes the risk of serious heart problems in adolescents and adults with severe asthma compared with high-intensity standard care.
-
Evaluating Tezepelumab for Adults with Moderate to Very Severe COPD
This study is testing if a new medication called tezepelumab can help adults with moderate to very severe COPD feel better and reduce flare-ups compared to a placebo.
-
Evaluating Tezepelumab for Adults with Moderate to Very Severe COPD
This study is testing if a new medication called tezepelumab can help adults with moderate to very severe COPD feel better and reduce their flare-ups over a treatment period of up to 76 weeks.
-
Tezepelumab for adults with severe asthma presenting to the emergency department
This study tests whether a monthly injection of tezepelumab, given in the emergency department, can reduce return visits for asthma flares in adults with severe asthma.
-
Evaluating tezepelumab for severe asthma in children aged 5 to under 12
This study is testing if a new asthma treatment called tezepelumab can help children aged 5 to under 12 who have severe asthma feel better and breathe easier.
Quick answers
How many clinical trials of Tezepelumab are recruiting right now?
11, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 40 countries. The most sites are in United States (5 trials), China (4 trials), Canada (3 trials), France (3 trials), United Kingdom (3 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 5, Phase 2: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.